6.2
Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are…
Adrenergic receptors, or adrenoceptors, respond to catecholamine agonists like NA, Adr, and ISO.
All adrenoceptors are G protein–coupled receptors with seven transmembrane helices.
Catecholamine binding induces a conformational change in the receptors. This allows G protein activation, which modifies the production of second messengers.
Adrenoceptors are classified as α- and β-adrenoceptors based on their sensitivity to various catecholamine agonists.
The α-adrenoceptors are weakly responsive to ISO compared to Adr, and NA. α-Adrenoceptors are further classified into α1 and α2 subtypes.
The ꞵ-adrenoceptors demonstrate higher sensitivity to ISO than Adr and NA. ꞵ-adrenoceptors are subdivided into ꞵ1, ꞵ2 , and ꞵ3 subtypes.
Effector organs innervated by adrenergic neurons typically have a predominant adrenoceptor subtype. For instance, though skeletal muscle vasculature has both α1- and ꞵ2-adrenoceptors, the ꞵ2 subtype predominates.
View the full transcript and gain access to JoVE Core videos
Q1: What are adrenergic receptors and how do they respond to catecholamines?
Adrenergic receptors, or adrenoceptors, are G protein-coupled receptors with seven transmembrane helices that respond to catecholamine agonists like noradrenaline, adrenaline, and isoproterenol. When catecholamines bind, they trigger a conformational change that activates G proteins, which then modify second messenger production to generate cellular responses.
Q2: How are alpha and beta adrenoceptors distinguished from each other?
Alpha-adrenoceptors are weakly responsive to isoproterenol but highly sensitive to noradrenaline and adrenaline. Beta-adrenoceptors demonstrate the opposite pattern, showing higher sensitivity to isoproterenol than to noradrenaline and adrenaline. This differential pharmacological response forms the basis for their classification and therapeutic targeting.
Q3: What are the subtypes of alpha-adrenoceptors and where are they located?
Alpha-adrenoceptors are subdivided into α1 and α2 subtypes. α1 adrenoceptors are found on postsynaptic effector cells, mainly in smooth muscles, with three subtypes: α1A, α1B, and α1D. α2 adrenoceptors are located in presynaptic adrenergic neurons, lipocytes, platelets, and smooth muscles, with three subtypes: α2A, α2B, and α2C.
Q4: What are the subtypes of beta-adrenoceptors and their primary locations?
Beta-adrenoceptors have three subtypes: β1, β2, and β3. β1 adrenoceptors are located postsynaptically on the heart, brain, and lipocytes, and presynaptically in adrenergic and cholinergic nerve terminals. β2 adrenoceptors are found on cardiac and smooth muscles, while β3 adrenoceptors are primarily involved in lipolysis and thermogenesis.
Q5: How do alpha-1 and alpha-2 adrenoceptors differ in their signaling mechanisms?
α1 adrenoceptor stimulation activates phospholipase C, producing IP3 and DAG as second messengers. α2 adrenoceptor activation inhibits adenylyl cyclase, decreasing cAMP levels, and modulates Ca2+ and K+ ion channels. These distinct signaling pathways allow α1 and α2 receptors to produce different physiological effects despite both being alpha-adrenoceptors.
Q6: What physiological effects result from beta-adrenoceptor stimulation?
β1 adrenoceptor stimulation increases heart rate and contraction force. β2 adrenoceptor stimulation causes bronchodilation, vasodilation, visceral smooth muscle relaxation, hepatic glycogenolysis, and muscle tremors. β3 adrenoceptor stimulation is responsible for lipolysis, thermogenesis, and relaxation of the detrusor muscle in the bladder.
Q7: Why do different effector organs respond differently to adrenergic stimulation?
Effector organs innervated by adrenergic neurons typically have a predominant adrenoceptor subtype that determines their response. For example, skeletal muscle vasculature has both α1 and β2 adrenoceptors, but the β2 subtype predominates, making vasodilation the dominant response. This differential receptor distribution allows tissue-specific physiological responses.